Viagra / Cialis (tadalafil / sildenafil)
Viagra (sildenafil) and Cialis (tadalafil) are prescription medications used to treat erectile dysfunction by increasing blood flow to the penis. They work by inhibiting the enzyme PDE5, which helps relax blood vessels and improve erectile response. Cialis has a longer duration of action, while Viagra is shorter acting, with both medications requiring sexual stimulation to be effective.
-
This page summarizes anecdotal reports and community observations, not medical evidence. Reports may be incomplete, biased or inaccurate and are not medical advice or recommendations. “Risk” here refers to how frequently severe or prolonged symptom worsening is reported, not to proven causation or population-wide probability. Individual responses vary widely, and absence of issues in some users does not rule out significant reactions in others.
-
Within PFS/PSSD/PAS communities, PDE5 inhibitors are discussed in relation to their potential interactions with nitric oxide signaling and vascular pathways. Cialis (tadalafil) and Viagra (sildenafil) are PDE5 inhibitors, prescription medications used primarily for erectile dysfunction (and, at different dosing, sometimes for pulmonary hypertension). They don't create an erection by themselves—rather, they support the normal erection pathway when sexual stimulation occurs. Mechanistically, sexual stimulation triggers nitric oxide (NO) release in penile tissue, which increases cGMP and relaxes smooth muscle so more blood can flow in; PDE5 inhibitors work by slowing cGMP breakdown, helping sustain that blood-flow response. In PFS/PSSD/PAS discussions, PDE5 inhibitors are often framed as symptom-support tools (blood flow/erection quality) rather than a direct "root-cause" intervention for suspected mechanisms (androgen signaling, neurosteroids/GABA changes, etc.). These mechanisms may interact with pathways involving nitric oxide signaling, cGMP regulation, or vascular function that are often discussed in relation to PFS / PSSD / PAS.
-
Mostly Well-Tolerated, With Documented Sensory Risks (for PFS/PSSD/PAS):
Among individuals with PFS, PSSD, or PAS, PDE5 inhibitors such as Viagra and Cialis are often reported as relatively well tolerated and commonly used for erectile support without obvious global destabilization. However, they are not considered risk-free, with community reports and medical labeling highlighting rare but meaningful adverse effects, particularly tinnitus or sudden hearing changes, which may be especially concerning for individuals already experiencing neurological or sensory sensitivity. While reported benefits are typically limited to erection firmness or maintenance—and sometimes reduced performance anxiety—these medications do not appear to address underlying baseline symptoms. Most adverse effects described improve after discontinuation, but the possibility of sensory or autonomic worsening leads many in the community to recommend cautious use and close monitoring.
For individuals without PFS, PSSD, or PAS, PDE5 inhibitors are widely prescribed and generally considered safe when used appropriately, though standard medical warnings still apply, including avoidance with nitrates and prompt medical attention for prolonged erections or sudden hearing changes.
Evidence Basis: Establish physiology/pharmacology of PDE5 inhibitors and NO–cGMP erection signaling; FDA labeling and safety warnings (including sudden hearing loss/tinnitus language); observational/pharmacovigilance literature on hearing impairment signals; anecdotal community reports.
-
Public comments reflect individual experiences and opinions. They are not medical advice and may not be accurate or representative.